1. Home
  2. HNNA vs BEAT Comparison

HNNA vs BEAT Comparison

Compare HNNA & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.32

Market Cap

76.4M

Sector

Finance

ML Signal

HOLD

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.72

Market Cap

63.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
BEAT
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
63.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HNNA
BEAT
Price
$10.32
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
6.3M
Earning Date
12-03-2025
11-13-2025
Dividend Yield
5.50%
N/A
EPS Growth
38.04
N/A
EPS
1.27
N/A
Revenue
$35,538,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.87
N/A
Revenue Growth
19.88
N/A
52 Week Low
$8.43
$0.54
52 Week High
$13.88
$3.48

Technical Indicators

Market Signals
Indicator
HNNA
BEAT
Relative Strength Index (RSI) 46.88 29.07
Support Level $9.33 $0.66
Resistance Level $10.39 $0.74
Average True Range (ATR) 0.32 0.17
MACD 0.02 -0.04
Stochastic Oscillator 61.47 15.08

Price Performance

Historical Comparison
HNNA
BEAT

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: